{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:17:07Z","timestamp":1770747427576,"version":"3.49.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s11910-017-0709-2","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T06:38:54Z","timestamp":1485239934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Autoimmune Movement Disorders: a Clinical and Laboratory Approach"],"prefix":"10.1007","volume":"17","author":[{"given":"Josephe Archie","family":"Honorat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"McKeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,24]]},"reference":[{"key":"709_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"709_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","volume":"122","author":"A McKeon","year":"2011","unstructured":"McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011;122:381\u2013400.","journal-title":"Acta Neuropathol"},{"key":"709_CR3","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000245","volume":"3","author":"JJ Linnoila","year":"2016","unstructured":"Linnoila JJ, Binnicker MJ, Majed M, et al. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3, e245.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"709_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"709_CR5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","volume":"68","author":"A McKeon","year":"2011","unstructured":"McKeon A, Tracy JA, Pittock SJ, et al. Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond. Arch Neurol. 2011;68:1282\u20139.","journal-title":"Arch Neurol"},{"key":"709_CR6","doi-asserted-by":"crossref","unstructured":"Cardoso F, Eduardo C, Silva AP, et al. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12:701\u20133.","DOI":"10.1002\/mds.870120512"},{"key":"709_CR7","doi-asserted-by":"crossref","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"709_CR8","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jamaneurol.2013.4442","volume":"70","author":"SL Clardy","year":"2013","unstructured":"Clardy SL, Lennon VA, Dalmau J, et al. Childhood onset of stiff-man syndrome. JAMA Neurol. 2013;70:1531\u20136.","journal-title":"JAMA Neurol"},{"key":"709_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(12)70319-8","volume":"12","author":"A McKeon","year":"2013","unstructured":"McKeon A. The importance of early and sustained treatment of a common autoimmune encephalitis. Lancet Neurol. 2013;12:123\u20135.","journal-title":"Lancet Neurol"},{"key":"709_CR10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","volume":"72","author":"AL Jones","year":"2015","unstructured":"Jones AL, Flanagan EP, Pittock SJ, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304\u201312. This study demonstrates that the type of the antibody and presence or absence of cancer influences the responses to treatment and outcomes in autoimmune cerebellar ataxia.","journal-title":"JAMA Neurol"},{"key":"709_CR11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","volume":"80","author":"O O\u2019Toole","year":"2013","unstructured":"O\u2019Toole O, Lennon VA, Ahlskog JE, et al. Autoimmune chorea in adults. Neurology. 2013;80:1133\u201344.","journal-title":"Neurology"},{"key":"709_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","volume":"392","author":"ML Albert","year":"1998","unstructured":"Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392:86\u20139.","journal-title":"Nature"},{"key":"709_CR13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","volume":"109","author":"SR Hinson","year":"2012","unstructured":"Hinson SR, Romero MF, Popescu BF, et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci U S A. 2012;109:1245\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"709_CR14","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","volume":"30","author":"EG Hughes","year":"2010","unstructured":"Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866\u201375.","journal-title":"J Neurosci"},{"key":"709_CR15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm892","volume":"9","author":"CA Kirvan","year":"2003","unstructured":"Kirvan CA, Swedo SE, Heuser JS, et al. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914\u201320.","journal-title":"Nat Med"},{"key":"709_CR16","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.151.5.2820","volume":"151","author":"MS Bronze","year":"1993","unstructured":"Bronze MS, Dale JB. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993;151:2820\u20138.","journal-title":"J Immunol"},{"key":"709_CR17","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135:3453\u201368.","journal-title":"Brain"},{"key":"709_CR18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/adc.2003.031880","volume":"89","author":"AJ Church","year":"2004","unstructured":"Church AJ, Dale RC, Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders? Arch Dis Child. 2004;89:611\u20134.","journal-title":"Arch Dis Child"},{"key":"709_CR19","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.4049\/jimmunol.178.11.7412","volume":"178","author":"CA Kirvan","year":"2007","unstructured":"Kirvan CA, Cox CJ, Swedo SE, et al. Tubulin is a neuronal target of autoantibodies in Sydenham\u2019s chorea. J Immunol. 2007;178:7412\u201321.","journal-title":"J Immunol"},{"key":"709_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-5728(03)00012-2","volume":"136","author":"AJ Church","year":"2003","unstructured":"Church AJ, Dale RC, Cardoso F, et al. CSF and serum immune parameters in Sydenham\u2019s chorea: evidence of an autoimmune syndrome? J Neuroimmunol. 2003;136:149\u201353.","journal-title":"J Neuroimmunol"},{"key":"709_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/08830738050200050601","volume":"20","author":"MA Garvey","year":"2005","unstructured":"Garvey MA, Snider LA, Leitman SF, et al. Treatment of Sydenham\u2019s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20:424\u20139.","journal-title":"J Child Neurol"},{"key":"709_CR22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.parkreldis.2011.12.013","volume":"18","author":"DP Maia","year":"2012","unstructured":"Maia DP, Fonseca PG, Camargos ST, et al. Pregnancy in patients with Sydenham\u2019s chorea. Parkinsonism Relat Disord. 2012;18:458\u201361.","journal-title":"Parkinsonism Relat Disord"},{"key":"709_CR23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaneurol.2013.4786","volume":"71","author":"MC Kruer","year":"2014","unstructured":"Kruer MC, Hoeftberger R, Lim KY, et al. Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity. JAMA Neurol. 2014;71:620\u20133.","journal-title":"JAMA Neurol"},{"key":"709_CR24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","volume":"51","author":"S Vernino","year":"2002","unstructured":"Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002;51:625\u201330.","journal-title":"Ann Neurol"},{"key":"709_CR25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49:146\u201354.","journal-title":"Ann Neurol"},{"key":"709_CR26","doi-asserted-by":"crossref","unstructured":"Ramdhani RA, Frucht SJ. Isolated chorea associated with LGI1 antibody. Tremor Other Hyperkinet Mov (N Y). 2014;4.","DOI":"10.5334\/tohm.214"},{"key":"709_CR27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575\u201386. This articles describes a new disorder characterized by IgLON5 antibodies, sleep disturbances and neurodegeneration.","journal-title":"Lancet Neurol"},{"key":"709_CR28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp.25.3.271","volume":"25","author":"M Kinsbourne","year":"1962","unstructured":"Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry. 1962;25:271\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"709_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","volume":"22","author":"NL Antunes","year":"2000","unstructured":"Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol. 2000;22:315\u201320.","journal-title":"J Pediatr Hematol Oncol"},{"key":"709_CR30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2015.07.007","volume":"286","author":"JA Panzer","year":"2015","unstructured":"Panzer JA, Anand R, Dalmau J, et al. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome. J Neuroimmunol. 2015;286:86\u201392.","journal-title":"J Neuroimmunol"},{"key":"709_CR31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2007.01.006","volume":"185","author":"S Beck","year":"2007","unstructured":"Beck S, Fuhlhuber V, Krasenbrink I, et al. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome. J Neuroimmunol. 2007;185:145\u20139.","journal-title":"J Neuroimmunol"},{"key":"709_CR32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, et al. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437\u201343.","journal-title":"Brain"},{"key":"709_CR33","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/archneurol.2012.1173","volume":"69","author":"JP Klaas","year":"2012","unstructured":"Klaas JP, Ahlskog JE, Pittock SJ, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012;69:1598\u2013607.","journal-title":"Arch Neurol"},{"key":"709_CR34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangue","year":"2016","unstructured":"Armangue T, Sabater L, Torres-Vega E, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 2016;73:417\u201324.","journal-title":"JAMA Neurol"},{"key":"709_CR35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jneuroim.2008.03.013","volume":"196","author":"L Sabater","year":"2008","unstructured":"Sabater L, Xifro X, Saiz A, et al. Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus. J Neuroimmunol. 2008;196:188\u201391.","journal-title":"J Neuroimmunol"},{"key":"709_CR36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s40064-015-1429-1","volume":"4","author":"S Syrbe","year":"2015","unstructured":"Syrbe S, Merkenschlager A, Bernhard MK, et al. Opsoclonus-myoclonus syndrome after adenovirus infection. Springerplus. 2015;4:636.","journal-title":"Springerplus"},{"key":"709_CR37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/cir711","volume":"54","author":"WJ Wiersinga","year":"2012","unstructured":"Wiersinga WJ, Prins JM, van de Beek D. Therapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection. Clin Infect Dis. 2012;54:447\u20138.","journal-title":"Clin Infect Dis"},{"key":"709_CR38","doi-asserted-by":"crossref","first-page":"785627","DOI":"10.1155\/2012\/785627","volume":"2012","author":"G Indolfi","year":"2012","unstructured":"Indolfi G, Bartolini E, Olivito B, et al. Autoimmunity and extrahepatic manifestations in treatment-naive children with chronic hepatitis C virus infection. Clin Dev Immunol. 2012;2012:785627.","journal-title":"Clin Dev Immunol"},{"key":"709_CR39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00431-009-1048-3","volume":"169","author":"BM Huber","year":"2010","unstructured":"Huber BM, Strozzi S, Steinlin M, et al. Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases. Eur J Pediatr. 2010;169:441\u20135.","journal-title":"Eur J Pediatr"},{"key":"709_CR40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clineuro.2008.03.005","volume":"110","author":"I Markakis","year":"2008","unstructured":"Markakis I, Alexiou E, Xifaras M, et al. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg. 2008;110:619\u201321.","journal-title":"Clin Neurol Neurosurg"},{"key":"709_CR41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13:276\u201386.","journal-title":"Lancet Neurol"},{"key":"709_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336.","journal-title":"Ann Neurol"},{"key":"709_CR43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","volume":"3","author":"LH Sansing","year":"2007","unstructured":"Sansing LH, Tuzun E, Ko MW, et al. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol. 2007;3:291\u20136.","journal-title":"Nat Clin Pract Neurol"},{"key":"709_CR44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365.","journal-title":"Lancet Neurol"},{"key":"709_CR45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clim.2016.03.011","volume":"166\u2013167","author":"M Jeraiby","year":"2016","unstructured":"Jeraiby M, Depince-Berger A, Bossy V, et al. A case of anti-NMDA receptor encephalitis in a woman with a NMDA-R(+) small cell lung carcinoma (SCLC). Clin Immunol. 2016;166\u2013167:96\u20139.","journal-title":"Clin Immunol"},{"key":"709_CR46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63\u201374.","journal-title":"Lancet Neurol"},{"key":"709_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","volume":"5","author":"M Manto","year":"2010","unstructured":"Manto M, Dalmau J, Didelot A, et al. In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction. Orphanet J Rare Dis. 2010;5:31.","journal-title":"Orphanet J Rare Dis"},{"key":"709_CR48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","volume":"77","author":"E Lancaster","year":"2011","unstructured":"Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77:179\u201389.","journal-title":"Neurology"},{"key":"709_CR49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","volume":"80","author":"J Planaguma","year":"2016","unstructured":"Planaguma J, Haselmann H, Mannara F, et al. Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity. Ann Neurol. 2016;80:388\u2013400. This study identifies a potential new mechanism in NMDA-R encephalitis that may be targeted by future novel therapeutics.","journal-title":"Ann Neurol"},{"key":"709_CR50","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","volume":"135","author":"L Mikasova","year":"2012","unstructured":"Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain. 2012;135:1606\u201321.","journal-title":"Brain"},{"key":"709_CR51","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","volume":"86","author":"N Gresa-Arribas","year":"2016","unstructured":"Gresa-Arribas N, Planaguma J, Petit-Pedrol M, et al. Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development. Neurology. 2016;86:2235\u201342.","journal-title":"Neurology"},{"key":"709_CR52","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264\u201371.","journal-title":"Am J Psychiatry"},{"key":"709_CR53","doi-asserted-by":"crossref","unstructured":"Swedo ES. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatrics & Therapeutics. 2012;02.","DOI":"10.4172\/2161-0665.1000113"},{"key":"709_CR54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2005.10.014","volume":"172","author":"RC Dale","year":"2006","unstructured":"Dale RC, Candler PM, Church AJ, et al. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol. 2006;172:187\u201397.","journal-title":"J Neuroimmunol"},{"key":"709_CR55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1089\/cap.2014.0048","volume":"25","author":"CJ Cox","year":"2015","unstructured":"Cox CJ, Zuccolo AJ, Edwards EV, et al. Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2015;25:76\u201385.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"709_CR56","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archneurol.2010.209","volume":"67","author":"SJ Pittock","year":"2010","unstructured":"Pittock SJ, Parisi JE, McKeon A, et al. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010;67:1109\u201315.","journal-title":"Arch Neurol"},{"key":"709_CR57","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/mds.25999","volume":"29","author":"SS Mohammad","year":"2014","unstructured":"Mohammad SS, Fung VS, Grattan-Smith P, et al. Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord. 2014;29:1539\u201342.","journal-title":"Mov Disord"},{"key":"709_CR58","first-page":"1359","volume":"20","author":"S Muppidi","year":"2014","unstructured":"Muppidi S, Vernino S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014;20:1359\u201372.","journal-title":"Continuum (Minneap Minn)"},{"key":"709_CR59","first-page":"11","volume":"1","author":"F Graus","year":"1986","unstructured":"Graus F, Elkon KB, Cordon-Cardo C, et al. Pure sensory neuropathy. Restriction of the Hu antibody to the sensory neuropathy associated with small cell carcinoma of the lung. Neurologia. 1986;1:11\u20135.","journal-title":"Neurologia"},{"key":"709_CR60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psym.2015.01.003","volume":"56","author":"JL Kruse","year":"2015","unstructured":"Kruse JL, Lapid MI, Lennon VA, et al. Psychiatric autoimmunity: N-methyl-D-aspartate receptor IgG and beyond. Psychosomatics. 2015;56:227\u201341.","journal-title":"Psychosomatics"},{"key":"709_CR61","first-page":"421","volume":"31","author":"FP Moersch","year":"1956","unstructured":"Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm (\u201cstiff-man\u201d syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin. 1956;31:421\u20137.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"709_CR62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/99.1.27","volume":"99","author":"AM Whiteley","year":"1976","unstructured":"Whiteley AM, Swash M, Urich H. Progressive encephalomyelitis with rigidity. Brain. 1976;99:27\u201342.","journal-title":"Brain"},{"key":"709_CR63","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","volume":"69","author":"A McKeon","year":"2012","unstructured":"McKeon A, Robinson MT, McEvoy KM, et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012;69:230\u20138.","journal-title":"Arch Neurol"},{"key":"709_CR64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.21374","volume":"22","author":"JC McHugh","year":"2007","unstructured":"McHugh JC, Murray B, Renganathan R, et al. GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord. 2007;22:1343\u20136.","journal-title":"Mov Disord"},{"key":"709_CR65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(01)00602-5","volume":"193","author":"H Hagiwara","year":"2001","unstructured":"Hagiwara H, Enomoto-Nakatani S, Sakai K, et al. Stiff-person syndrome associated with invasive thymoma: a case report. J Neurol Sci. 2001;193:59\u201362.","journal-title":"J Neurol Sci"},{"key":"709_CR66","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mus.23706","volume":"47","author":"G Rakocevic","year":"2013","unstructured":"Rakocevic G, Hussain A. Stiff person syndrome improvement with chemotherapy in a patient with cutaneous T cell lymphoma. Muscle Nerve. 2013;47:938\u20139.","journal-title":"Muscle Nerve"},{"key":"709_CR67","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Yoshikawa H, Ahlskog JE, et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc. 2006;81:1207\u201314.","journal-title":"Mayo Clin Proc"},{"key":"709_CR68","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5334\/tohm.316","volume":"6","author":"H Sarva","year":"2016","unstructured":"Sarva H, Deik A, Ullah A, et al. Clinical spectrum of stiff person syndrome: a review of recent reports. Tremor Hyperkinet Mov (N Y). 2016;6:340.","journal-title":"Tremor Hyperkinet Mov (N Y)"},{"key":"709_CR69","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Arino","year":"2015","unstructured":"Arino H, Hoftberger R, Gresa-Arribas N, et al. Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol. 2015;72:874\u201381.","journal-title":"JAMA Neurol"},{"key":"709_CR70","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonzalez","year":"2014","unstructured":"Carvajal-Gonzalez A, Leite MI, Waters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014;137:2178\u201392.","journal-title":"Brain"},{"key":"709_CR71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2013.574","volume":"70","author":"A McKeon","year":"2013","unstructured":"McKeon A, Martinez-Hernandez E, Lancaster E, et al. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013;70:44\u201350.","journal-title":"JAMA Neurol"},{"key":"709_CR72","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamaneurol.2016.0133","volume":"73","author":"E Martinez-Hernandez","year":"2016","unstructured":"Martinez-Hernandez E, Arino H, McKeon A, et al. Clinical and immunologic investigations in patients with stiff-person spectrum disorder. JAMA Neurol. 2016;73:714\u201320.","journal-title":"JAMA Neurol"},{"key":"709_CR73","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.wnl.0000327342.58936.e0","volume":"71","author":"BB Murinson","year":"2008","unstructured":"Murinson BB, Guarnaccia JB. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology. 2008;71:1955\u20138.","journal-title":"Neurology"},{"key":"709_CR74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58:96\u2013107.","journal-title":"Ann Neurol"},{"key":"709_CR75","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","volume":"133","author":"C Geis","year":"2010","unstructured":"Geis C, Weishaupt A, Hallermann S, et al. Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain. 2010;133:3166\u201380.","journal-title":"Brain"},{"key":"709_CR76","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1034\/j.1600-0854.2002.30702.x","volume":"3","author":"B Zhang","year":"2002","unstructured":"Zhang B, Zelhof AC. Amphiphysins: raising the BAR for synaptic vesicle recycling and membrane dynamics. Bin-Amphiphysin-Rvsp Traffic. 2002;3:452\u201360.","journal-title":"Bin-Amphiphysin-Rvsp Traffic"},{"key":"709_CR77","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, et al. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014;83:1797\u2013803.","journal-title":"Neurology"},{"key":"709_CR78","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/WNL.0000000000000372","volume":"82","author":"B Balint","year":"2014","unstructured":"Balint B, Jarius S, Nagel S, et al. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies. Neurology. 2014;82:1521\u20138.","journal-title":"Neurology"},{"key":"709_CR79","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.neuron.2011.08.008","volume":"71","author":"W Sun","year":"2011","unstructured":"Sun W, Maffie JK, Lin L, et al. DPP6 establishes the A-type K(+) current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons. Neuron. 2011;71:1102\u201315.","journal-title":"Neuron"},{"key":"709_CR80","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, Holtje M, Michel K, et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85:890\u20137. This article describes the mechanisms of DPPX -IgG-induced symptomatology.","journal-title":"Neurology"},{"key":"709_CR81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneurol.2011.56","volume":"68","author":"C Adams","year":"2011","unstructured":"Adams C, McKeon A, Silber MH, et al. Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma. Arch Neurol. 2011;68:521\u20134.","journal-title":"Arch Neurol"},{"key":"709_CR82","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","volume":"30","author":"Y Compta","year":"2007","unstructured":"Compta Y, Iranzo A, Santamaria J, et al. REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep. 2007;30:767\u20139.","journal-title":"Sleep"},{"key":"709_CR83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.21314","volume":"22","author":"L Matsumoto","year":"2007","unstructured":"Matsumoto L, Yamamoto T, Higashihara M, et al. Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes. Mov Disord. 2007;22:728\u201331.","journal-title":"Mov Disord"},{"key":"709_CR84","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831\u201344.","journal-title":"Brain"},{"key":"709_CR85","doi-asserted-by":"crossref","unstructured":"Ortega Suero G, Sola-Valls N, Escudero D, et al. Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes. Neurologia. 2016.","DOI":"10.1016\/j.nrl.2016.05.010"},{"key":"709_CR86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.wnl.0000223647.83708.20","volume":"67","author":"DT Blumenthal","year":"2006","unstructured":"Blumenthal DT, Salzman KL, Digre KB, et al. Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology. 2006;67:146\u20139.","journal-title":"Neurology"},{"key":"709_CR87","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1442-2042.2008.02119.x","volume":"15","author":"M Kimura","year":"2008","unstructured":"Kimura M, Onozawa M, Fujisaki A, et al. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin. Int J Urol. 2008;15:942\u20133.","journal-title":"Int J Urol"},{"key":"709_CR88","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","volume":"70","author":"KM Tan","year":"2008","unstructured":"Tan KM, Lennon VA, Klein CJ, et al. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2008;70:1883\u201390.","journal-title":"Neurology"},{"key":"709_CR89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2016.01.006","volume":"362","author":"S Kannoth","year":"2016","unstructured":"Kannoth S, Anandakkuttan A, Mathai A, et al. Autoimmune atypical parkinsonism\u2014a group of treatable parkinsonism. J Neurol Sci. 2016;362:40\u20136.","journal-title":"J Neurol Sci"},{"key":"709_CR90","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","volume":"21","author":"MM Kurtis","year":"2015","unstructured":"Kurtis MM, Toledano R, Garcia-Morales I, et al. Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis. Parkinsonism Relat Disord. 2015;21:1286\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"709_CR91","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","volume":"42","author":"K Peterson","year":"1992","unstructured":"Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42:1931\u20137.","journal-title":"Neurology"},{"key":"709_CR92","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0000000000002476","volume":"86","author":"AS Lopez-Chiriboga","year":"2016","unstructured":"Lopez-Chiriboga AS, Komorowski L, Kumpfel T, et al. Metabotropic glutamate receptor type 1 autoimmunity: clinical features and treatment outcomes. Neurology. 2016;86:1009\u201313. This study presents the clinical characteristics, cancer association and responses to treatment of mGluR1-associated cerebellar ataxia.","journal-title":"Neurology"},{"key":"709_CR93","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"709_CR94","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12974-015-0356-y","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u2018Medusa-head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: anti-mGluR1, anti-Homer-3, anti-Sj\/ITPR1 and anti-CARP VIII. J Neuroinflammation. 2015;12:166.","journal-title":"J Neuroinflammation"},{"key":"709_CR95","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-015-0358-9","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo\/CDR2, anti-Nb\/AP3B2, PCA-2, anti-Tr\/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:168.","journal-title":"J Neuroinflammation"},{"key":"709_CR96","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-015-0357-x","volume":"12","author":"S Jarius","year":"2015","unstructured":"Jarius S, Wildemann B. \u2018Medusa head ataxia\u2019: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: anti-PKC-gamma, anti-GluR-delta2, anti-Ca\/ARHGAP26 and anti-VGCC. J Neuroinflammation. 2015;12:167.","journal-title":"J Neuroinflammation"},{"key":"709_CR97","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/WCO.0000000000000351","volume":"29","author":"B Balint","year":"2016","unstructured":"Balint B, Bhatia KP. Stiff person syndrome and other immune-mediated movement disorders\u2014new insights. Curr Opin Neurol. 2016;29:496\u2013506.","journal-title":"Curr Opin Neurol"},{"key":"709_CR98","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-444-63432-0.00017-7","volume":"133","author":"A McKeon","year":"2016","unstructured":"McKeon A, Vincent A. Autoimmune movement disorders. Handb Clin Neurol. 2016;133:301\u201315.","journal-title":"Handb Clin Neurol"},{"key":"709_CR99","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R Hoftberger","year":"2013","unstructured":"Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology. 2013;81:1500\u20136.","journal-title":"Neurology"},{"key":"709_CR100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167\u201377.","journal-title":"Lancet Neurol"},{"key":"709_CR101","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","volume":"127","author":"A Vincent","year":"2004","unstructured":"Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701\u201312.","journal-title":"Brain"},{"key":"709_CR102","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000231","volume":"3","author":"M Majed","year":"2016","unstructured":"Majed M, Fryer JP, McKeon A, et al. Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm. 2016;3, e231.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"709_CR103","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","volume":"67","author":"A McKeon","year":"2010","unstructured":"McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol. 2010;67:322\u20139. This article presents in details the immunotherapy regimens for autoimmune neurological diseases.","journal-title":"Arch Neurol"},{"key":"709_CR104","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11940-013-0251-8","volume":"15","author":"A McKeon","year":"2013","unstructured":"McKeon A. Immunotherapeutics for autoimmune encephalopathies and dementias. Curr Treat Options Neurol. 2013;15:723\u201337.","journal-title":"Curr Treat Options Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-017-0709-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-017-0709-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T22:28:15Z","timestamp":1692656895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-017-0709-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["709"],"URL":"https:\/\/doi.org\/10.1007\/s11910-017-0709-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"article-number":"4"}}